Retinopathy Of Prematurity Rop clinical trials

Explore recruiting retinopathy of prematurity rop clinical trials.

Recruiting retinopathy of prematurity rop studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Retinopathy Of Prematurity Rop trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Extension Study to Evaluate the Long-Term Outcomes of Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study

Romania, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Klonidin as pain relief in eye examination of premature infants - cloROP

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

(20275) An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090

Sweden, Italy, Portugal, Bulgaria, Romania, Belgium +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Safety of ELGN-2112 in Populations of Interest

Netherlands, Spain, Austria, France, Italy, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants

Austria, Netherlands, Spain, Sweden, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I single arm, dose escalating and phase II double blind, randomized, placebo-controlled dose finding clinical trial assessing safety, and efficacy of intratracheal administration of allogeneic umbilical mesenchymal cells-derived extracellular vesicles in preventing bronchopulmonary dysplasia in extremely preterm newborns.

Italy, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Retinopathy Of Prematurity Rop trials by city

Retinopathy Of Prematurity Rop in Toronto Retinopathy Of Prematurity Rop in Vancouver Retinopathy Of Prematurity Rop in Montreal Retinopathy Of Prematurity Rop in Calgary Retinopathy Of Prematurity Rop in Edmonton Retinopathy Of Prematurity Rop in Ottawa Retinopathy Of Prematurity Rop in Winnipeg Retinopathy Of Prematurity Rop in Quebec City Retinopathy Of Prematurity Rop in Hamilton Retinopathy Of Prematurity Rop in Kitchener Retinopathy Of Prematurity Rop in London Retinopathy Of Prematurity Rop in Halifax Retinopathy Of Prematurity Rop in New York Retinopathy Of Prematurity Rop in Los Angeles Retinopathy Of Prematurity Rop in Chicago Retinopathy Of Prematurity Rop in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease